Danaher Corporation (DHR) Stock Forecast
US · Healthcare
Current price
$193.21
Market cap
$136.75B
Mean price target
$242.35
Implied upside
25.4%
Key takeaways
- Analysts rate Danaher Corporation a “Strong Buy”, with a mean price target of $242.35 — about 25.4% upside from the current $193.21, based on 23 analysts.
- DHR is trading in the middle of its 52-week range, at 39% of the $160.93–$242.80 band.
Analyst consensus
| Consensus rating | Strong Buy |
|---|---|
| Number of analysts | 23 |
| Mean target | $242.35 |
| High target | $310.00 |
| Low target | $200.00 |
| Rating split (SB / B / H / S / SS) | 4 / 18 / 3 / 0 / 0 |
Price & trading
| Current price | $193.21 |
|---|---|
| Previous close | $188.87 |
| 52-week high | $242.80 |
| 52-week low | $160.93 |
| 50-day average | $178.90 |
| Beta | 0.83 |
See the full DHR breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current Danaher Corporation (DHR) share price?
- Danaher Corporation last traded at $193.21 with a market capitalisation of about $136.7B.
- What is the analyst price target for DHR?
- The mean analyst price target for Danaher Corporation is $242.35, roughly 25.4% above the latest price. The current consensus rating is “Strong Buy”.
- Where can I see Danaher Corporation's full financial metrics?
- Luminoso tracks DHR's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.